InVivo Therapeutics Corp EV/EBIT
Was ist das EV/EBIT von InVivo Therapeutics Corp?
EV/EBIT von InVivo Therapeutics Holdings Corp ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu InVivo Therapeutics Corp
Was macht InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Unternehmen mit ev/ebit ähnlich InVivo Therapeutics Corp
- Aurum Resources Ltd hat EV/EBIT von N/A
- Aduro BioTech hat EV/EBIT von N/A
- Quintana Services hat EV/EBIT von N/A
- Maple Peak Investments hat EV/EBIT von N/A
- Inovio Pharmaceuticals Inc hat EV/EBIT von N/A
- Zoom Telephonics hat EV/EBIT von N/A
- InVivo Therapeutics Corp hat EV/EBIT von N/A
- Natures Hemp hat EV/EBIT von N/A
- Pulmatrix Inc hat EV/EBIT von N/A
- Techindia Nirman hat EV/EBIT von N/A
- Larimar Therapeutics hat EV/EBIT von N/A
- Epigenomics AG hat EV/EBIT von N/A
- Internet of Things hat EV/EBIT von N/A